Literature DB >> 22115790

A study to quantify the effectiveness of daily endorectal balloon for prostate intrafraction motion management.

Ken Kang-Hsin Wang1, Neha Vapiwala, Curtiland Deville, John P Plastaras, Ryan Scheuermann, Haibo Lin, Voika Bar Ad, Zelig Tochner, Stefan Both.   

Abstract

PURPOSE: To quantify intrafraction prostate motion between patient groups treated with and without daily endorectal balloon (ERB) employed during prostate radiotherapy and establish the effectiveness of the ERB.
METHODS: Real-time intrafraction prostate motion from 29 non-ERB (1,061 sessions) and 30 ERB (1,008 sessions) patients was evaluated based on three-dimensional (3D), left, right, cranial, caudal, anterior, and posterior displacements. The average percentage of time with 3D and unidirectional prostate displacements >2, 3, 4, 5, 6, 7, 8, 9, and 10 mm in 1-min intervals was calculated for up to 6 min of treatment time. The Kolmogorov-Smirnov method was used to evaluate the intrafraction prostate motion pattern between both groups.
RESULTS: Large 3D motion (up to 1 cm or more) was only observed in the non-ERB group. The motion increased as a function of elapsed time for displacements >2-8 mm for the non-ERB group and >2-4 mm for the ERB group (p < 0.05). The percentage time distributions between the two groups were significantly different for motion >5 mm (p < 0.05). The 3D symmetrical internal margin (IM) can be reduced from 5 to 3 mm (40% reduction), whereas the asymmetrical IM can be reduced from 3 to 2 mm (33% reduction) in cranial, caudal, anterior, and posterior for 6 min of treatment, when ERB is used. Beyond 6 min, the symmetrical 3D and asymmetrical cranial, caudal, anterior, and posterior IMs can be reduced from 9, 4, 7, 7, and 8 to 5, 2, 5, 3, and 4 mm, respectively (up to 57% reduction).
CONCLUSION: The percentage of time that the prostate was displaced in any direction was less in the ERB group for almost all magnitudes of motion considered. The directional analysis shows that the ERB reduced IMs in almost all directions, especially the anterior-posterior direction. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22115790     DOI: 10.1016/j.ijrobp.2011.07.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer: a study of 2940 setup deviations in 980 MVCTs.

Authors:  Kilian Schiller; Alessia Petrucci; Hans Geinitz; Tibor Schuster; Hanno Specht; Severin Kampfer; Marciana Nona Duma
Journal:  Strahlenther Onkol       Date:  2014-04-23       Impact factor: 3.621

2.  Prefraction displacement and intrafraction drift of the prostate due to perineal ultrasound probe pressure.

Authors:  Minglun Li; Nina-Sophie Hegemann; Farkhad Manapov; Anne Kolberg; Patrick Dominik Thum; Ute Ganswindt; Claus Belka; Hendrik Ballhausen
Journal:  Strahlenther Onkol       Date:  2017-02-14       Impact factor: 3.621

3.  Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy.

Authors:  M Geier; S T Astner; M N Duma; V Jacob; C Nieder; J Putzhammer; C Winkler; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-02-26       Impact factor: 3.621

4.  Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.

Authors:  F Böckelmann; M Hammon; S Lettmaier; R Fietkau; C Bert; F Putz
Journal:  Strahlenther Onkol       Date:  2018-10-12       Impact factor: 3.621

Review 5.  Effectiveness of rectal displacement devices in managing prostate motion: a systematic review.

Authors:  Mahdieh Afkhami Ardekani; Hamed Ghaffari; Mahmoud Navaser; Seyed Hamid Zoljalali Moghaddam; Soheila Refahi
Journal:  Strahlenther Onkol       Date:  2020-05-22       Impact factor: 3.621

6.  Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?

Authors:  Vivek Verma; Shifeng Chen; Sumin Zhou; Charles A Enke; Andrew O Wahl
Journal:  Strahlenther Onkol       Date:  2016-12-01       Impact factor: 3.621

Review 7.  Reducing rectal injury during external beam radiotherapy for prostate cancer.

Authors:  Riccardo Valdagni; Tiziana Rancati
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

Review 8.  Target margins in radiotherapy of prostate cancer.

Authors:  Slav Yartsev; Glenn Bauman
Journal:  Br J Radiol       Date:  2016-07-20       Impact factor: 3.039

9.  Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients - Long term data on toxicity and biochemical control.

Authors:  Kilian Schiller; Michael Geier; Marciana Nona Duma; Carsten Nieder; Michael Molls; Stephanie E Combs; Hans Geinitz
Journal:  Rep Pract Oncol Radiother       Date:  2019-05-30

10.  Real-time prostate motion assessment: image-guidance and the temporal dependence of intra-fraction motion.

Authors:  Avilash K Cramer; Amanu G Haile; Sanja Ognjenovic; Tulsee S Doshi; William Matthew Reilly; Katherine E Rubinstein; Nima Nabavizadeh; Thuan Nguyen; Lu Z Meng; Martin Fuss; James A Tanyi; Arthur Y Hung
Journal:  BMC Med Phys       Date:  2013-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.